Recently, we uncovered that tumor-localized fixation of LOX-based nanoreactors could effectively convert the PUFAs of tumor debris released during radiofrequency ablation to corresponding lipid peroxides and thus suppress the growth of residual cancer cells by causing ferroptosis [33]. This evidence concerns the gene LOX and cancer.